Skip to main content

Closed

MRK: Merck & Co., Inc. Stock Analysis | finqOS

Healthcare · Drug Manufacturers - General

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Revenue growth+1.2% / yr

Operating margin27.6%

ROIC13.3%

Financially safe

Strong

Debt / equity1.07×

Interest coverage17.4×

Current ratio1.30×

Valuation

Unrated

P/E ratio36.6×

Dividend yield2.6%

Merck & Co., Inc.

MRKNew York Stock Exchange·USD·Closed

Merck & Co., Inc.

MRKNew York Stock Exchange·USD·Closed

$130.22

+0.33%

$130.22

+$0.43 (0.33%)

52W Range

92thpctl

Volume

0.46×avg

Mkt Cap

321.62BUSD

P/E

36.6TTM

Div Yield

2.58%ann

52W Range

92thpctl

Volume

0.46×avg

Market Cap

321.62BUSD

P/E Ratio

36.6TTM

Div Yield

2.58%ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings